Literature DB >> 4335019

The influence of complement on cytomegalovirus neutralization by antibodies.

H K Andersen.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4335019     DOI： 10.1007/bf01250303

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  13 in total

1.  A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS.

Authors:  G PLUMMER; M BENYESH-MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  VIROLOGIC STUDIES ON CYTOMEGALIC INCLUSION DISEASE.

Authors:  G CARLSTROEM
Journal:  Acta Paediatr Scand       Date:  1965-01

3.  Serologic differentiation of viruses responsible for cytomegalic inclusion disease.

Authors:  T H WELLER; J B HANSHAW; D E SCOTT
Journal:  Virology       Date:  1960-09       Impact factor: 3.616

4.  Cytomegalovirus neutralization by plaque reduction.

Authors:  H K Andersen
Journal:  Arch Gesamte Virusforsch       Date:  1971

5.  Serologic differentiation of human cytomegalovirus strains using rabbit hyperimmune sera. Brief report.

Authors:  H K Andersen
Journal:  Arch Gesamte Virusforsch       Date:  1971

6.  Complement-fixing and virus-neutralizing antibodies in cytomegalovirus infection as measured against homologous and heterologous antigen.

Authors:  H K Andersen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

7.  Preparation of rabbit immune serum with neutralizing activity against a simian cytomegalovirus (SA6).

Authors:  D V Ablashi; L M Martos; R V Gilden; B Hampar
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

8.  Isolation of specific antibodies by Sephadex filtration at pH 3.

Authors:  T Hjort
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

9.  Rubella virus neutralization in heated sera.

Authors:  J Leerhoy
Journal:  Acta Pathol Microbiol Scand       Date:  1968

10.  Complement components required for virus neutralization by early immunoglobulin antibody.

Authors:  W D Linscott; W E Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205
View more
  10 in total

1.  Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

2.  Studies on human cytomegalovirus strain variations by membrane-fluorescence.

Authors:  E Gönczöl; H K Andersen
Journal:  Arch Gesamte Virusforsch       Date:  1974

3.  Studies of human cytomegalovirus strain variations by kinetic neutralization tests.

Authors:  H K Andersen
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Cytomegalovirus neutralization by plaque reduction.

Authors:  H K Andersen
Journal:  Arch Gesamte Virusforsch       Date:  1971

5.  Interaction of cytomegalovirus immune complexes with host cells.

Authors:  B B Rundell; R F Betts
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

6.  Isolation and characterization of two new herpes-like viruses from capuchin monkeys.

Authors:  M A Lewis; L D Frye; C J Gibbs; S M Chou; E C Cutchins; D C Gajdusek; G Ward
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Influence of complement on the neutralization of murine cytomegalovirus by rabbit antibody.

Authors:  K S Kim; R I Carp
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

8.  Antibody class and complement requirement of neutralizing antibodies in the primary and secondary antibody response of cattle to infectious bovine rhinotracheitis virus vaccine.

Authors:  C R Rossi; G K Kiesel
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  Evaluation of murine cytomegalovirus antibody detection by serological techniques.

Authors:  C A Anderson; J C Murphy; J G Fox
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

Review 10.  Neutralization of animal viruses.

Authors:  B Mandel
Journal:  Adv Virus Res       Date:  1978       Impact factor: 9.937
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.